Editorial

March 31, 2025


Editorial for JUO 2025 Vol. 23 No. 1 - Highlights of This Issue’s Papers and the JUO Editors’ Pick
Cheol Kwak
J Urol Oncol. 2025;23(1):1-3.

Invited Review

March 31, 2025


Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review
Gabriela M. Diaz, Peter S. Palencia, Michael S. Leapman
J Urol Oncol. 2025;23(1):4-13.

Original Article

March 31, 2025


The Clinical Impact of Depression and Anxiety on Complications After Prostate Cancer Treatment: A Retrospective Cohort Study
Elliott J. Druten, Will P. Hoover, Jacob Bardell, et al.
J Urol Oncol. 2025;23(1):14-19.

Original Article

March 31, 2025


A Urologist’s Perspective: Initial Experiences With SpaceOAR Hydrogel Insertion for Prostate Cancer Patients
Hyunho Han, Ik Jae Lee, Woong Sub Koom, et al.
J Urol Oncol. 2025;23(1):20-29.

Original Article

March 31, 2025


Prognostic Impact of Seminal Vesicle Mucosal Invasion in pT3b Prostate Cancer Following Radical Prostatectomy
Hyun Jung Lee, Won Hoon Song, Seung Soo Lee, et al.
J Urol Oncol. 2025;23(1):30-37.

Invited Review

March 31, 2025


Selection of Optimal Neoadjuvant Therapy Before Cytoreductive Nephrectomy and Its Biomarker in Renal Cell Carcinoma
Renpei Kato
J Urol Oncol. 2025;23(1):38-46.

Original Article

March 31, 2025


Predicting Oncological and Functional Outcomes by Nephrectomy Type for T1 Renal Tumors Using Machine Learning Models
Dongrul Shin, Maisy Song, Jungyo Suh, et al.
J Urol Oncol. 2025;23(1):47-53.

Original Article

March 31, 2025


Prognostic Implications of Serum Carbonic Anhydrase IX in Clear Cell Renal Cell Carcinoma
Mónica Sanz del Pozo, Cristina Plaza Alonso, Álvaro Linacero Gracia, et al.
J Urol Oncol. 2025;23(1):54-62.

Invited Review

March 31, 2025


A Review of Emerging Neoadjuvant Intravesical Strategies to Enhance Systemic Immune Checkpoint Blockade in Patients With Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Through the Induction of Immunogenic Cell Death and Activation of Tertiary Lymphoid Structure formation
Hye Won Lee, Hyun Hwan Sung
J Urol Oncol. 2025;23(1):63-78.

Original Article

March 31, 2025


Impact of Extended Lymph Node Dissection on Survival Outcomes in Patients With Bladder Cancer and Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study
Jiwoong Yu, Wook Nam, Kyung Hwan Kim, et al.
J Urol Oncol. 2025;23(1):79-87.

Original Article

March 31, 2025


Gender and Menopause Impact on Recurrence and Cancer-Specific Mortality in Bladder Cancer After Radical Cystectomy: A Retrospective Cohort Study
Jee Soo Park, Won Sik Jang, Jieun Heo, et al.
J Urol Oncol. 2025;23(1):88-93.
Editorial for JUO 2025 Vol. 23 No. 1 - Highlights of This Issue’s Papers and the JUO Editors’ Pick
Cheol Kwak
J Urol Oncol. 2025;23(1):1-3.

Editorial

Mar 31, 2025

Delivering on the Promise of Precision Oncology in Prostate Cancer: Prediagnostic Strategies, Postdiagnostic Applications, and Future Directions. A Narrative Review
Gabriela M. Diaz, Peter S. Palencia, Michael S. Leapman
J Urol Oncol. 2025;23(1):4-13.

Invited Review

Mar 31, 2025

Prostate Cancer
The Clinical Impact of Depression and Anxiety on Complications After Prostate Cancer Treatment: A Retrospective Cohort Study
Elliott J. Druten, Will P. Hoover, Jacob Bardell, et al.
J Urol Oncol. 2025;23(1):14-19.

Original Article

Mar 31, 2025

Prostate Cancer
A Urologist’s Perspective: Initial Experiences With SpaceOAR Hydrogel Insertion for Prostate Cancer Patients
Hyunho Han, Ik Jae Lee, Woong Sub Koom, et al.
J Urol Oncol. 2025;23(1):20-29.

Original Article

Mar 31, 2025

Prostate Cancer
Prognostic Impact of Seminal Vesicle Mucosal Invasion in pT3b Prostate Cancer Following Radical Prostatectomy
Hyun Jung Lee, Won Hoon Song, Seung Soo Lee, et al.
J Urol Oncol. 2025;23(1):30-37.

Original Article

Mar 31, 2025

Prostate Cancer
Selection of Optimal Neoadjuvant Therapy Before Cytoreductive Nephrectomy and Its Biomarker in Renal Cell Carcinoma
Renpei Kato
J Urol Oncol. 2025;23(1):38-46.

Invited Review

Mar 31, 2025

Kidney Cancer
Predicting Oncological and Functional Outcomes by Nephrectomy Type for T1 Renal Tumors Using Machine Learning Models
Dongrul Shin, Maisy Song, Jungyo Suh, et al.
J Urol Oncol. 2025;23(1):47-53.

Original Article

Mar 31, 2025

Kidney Cancer
Prognostic Implications of Serum Carbonic Anhydrase IX in Clear Cell Renal Cell Carcinoma
Mónica Sanz del Pozo, Cristina Plaza Alonso, Álvaro Linacero Gracia, et al.
J Urol Oncol. 2025;23(1):54-62.

Original Article

Mar 31, 2025

Kidney Cancer
A Review of Emerging Neoadjuvant Intravesical Strategies to Enhance Systemic Immune Checkpoint Blockade in Patients With Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Through the Induction of Immunogenic Cell Death and Activation of Tertiary Lymphoid Structure formation
Hye Won Lee, Hyun Hwan Sung
J Urol Oncol. 2025;23(1):63-78.

Invited Review

Mar 31, 2025

Bladder Cancer
Impact of Extended Lymph Node Dissection on Survival Outcomes in Patients With Bladder Cancer and Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study
Jiwoong Yu, Wook Nam, Kyung Hwan Kim, et al.
J Urol Oncol. 2025;23(1):79-87.

Original Article

Mar 31, 2025

Bladder Cancer
Gender and Menopause Impact on Recurrence and Cancer-Specific Mortality in Bladder Cancer After Radical Cystectomy: A Retrospective Cohort Study
Jee Soo Park, Won Sik Jang, Jieun Heo, et al.
J Urol Oncol. 2025;23(1):88-93.

Original Article

Mar 31, 2025

Bladder Cancer

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043


Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac

Copyright © The Korean Urological Oncology Society.

Developed in M2PI